1-5 of 5
John PERNOW
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase

John Tengbom, Eftychia Kontidou, Aida Collado, Jiangning Yang, Michael Alvarsson, Jonas Brinck, Sophia Rössner, Zhichao Zhou, John Pernow, Ali Mahdi
Journal: Clinical Science
Clin Sci (Lond) (2024) 138 (15): 975–985.
https://doi.org/10.1042/CS20240447
Published: 05 August 2024
View article titled, Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase
Open the PDF for Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase in another window
Articles

The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans

Felix BÖHM, Magnus SETTERGREN, Adrian T. GONON, John PERNOW
Journal: Clinical Science
Clin Sci (Lond) (2005) 108 (4): 357–363.
https://doi.org/10.1042/CS20040317
Published: 22 March 2005
View article titled, The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans
Open the PDF for The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans in another window
Articles

ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men

Felix BÖHM, John PERNOW, Jonas LINDSTRÖM, Gunvor AHLBORG
Journal: Clinical Science
Clin Sci (Lond) (2003) 104 (2): 143–151.
https://doi.org/10.1042/cs1040143
Published: 17 January 2003
View article titled, ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men
Open the PDF for ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men in another window
Articles

Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction

Bengt ULLMAN, John PERNOW, Jan M. LUNDBERG, Hans ÅSTRÖM, Lennart BERGFELDT
Journal: Clinical Science
Clin Sci (Lond) (2002) 103 (6): 535–542.
https://doi.org/10.1042/cs1030535
Published: 30 October 2002
View article titled, Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction
Open the PDF for Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction in another window
Articles

Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis

Felix BÖHM, Gunvor AHLBORG, John PERNOW
Journal: Clinical Science
Clin Sci (Lond) (2002) 102 (3): 321–327.
https://doi.org/10.1042/cs1020321
Published: 12 February 2002
View article titled, Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis
Open the PDF for Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis in another window